Rana A Qadeer1, Kathy Georgiades2, Michael H Boyle2, Mark A Ferro3. 1. 1 Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada. 2. 2 Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada. 3. 3 School of Public Health and Health Systems, University of Waterloo, Waterloo, Ontario, Canada.
Abstract
OBJECTIVES: We investigated the prevalence of substance use disorders (SUDs) among emerging adults and quantified the extent to which emerging adults, compared with young adults, have increased odds for SUDs. METHODS: Data were from the 2012 Canadian Community Health Survey-Mental Health (CCHS-MH). Respondents were 15 to 39 y of age ( n = 9228) and were categorized as: early emerging adults (15 to 22 y); late emerging adults (23 to 29 y); and, young adults (30 to 39 y). SUDs [alcohol or drug abuse/dependence (AAD or DAD)] were measured using the WHO Composite International Diagnostic Interview 3.0. The prevalence of SUDs was compared across age groups, and odds ratios (OR) and 95% confidence intervals (CI) were computed from logistic regression models adjusting for sociodemographic and health covariates. Analyses were weighted to maintain representativeness to the Canadian population. RESULTS: The prevalence of AAD was 8.0%, 6.6%, and 2.7% for early emerging adults, late emerging adults, and young adults, respectively. For DAD, the prevalence was 6.4%, 3.6%, and 1.3%. After covariate adjustment, early and late emerging adults had greater odds of reporting AAD (OR = 3.2, 95% CI = 2.2 to 4.9 and OR = 2.4, 95% CI = 1.6 to 3.4, respectively) or DAD (OR = 4.2, 95% CI = 2.5 to 7.0 and OR = 2.5, 95% CI = 1.6 to 4.1, respectively) compared with young adults. Differences between early and late emerging adults were not significant. CONCLUSION: Emerging adults are at increased odds for SUDs. Lack of differences between early and late emerging adults provide evidence of the extension of emerging adulthood into the late 20s. Findings have implications for the provision of screening and treatment of SUDs during this developmental period.
OBJECTIVES: We investigated the prevalence of substance use disorders (SUDs) among emerging adults and quantified the extent to which emerging adults, compared with young adults, have increased odds for SUDs. METHODS: Data were from the 2012 Canadian Community Health Survey-Mental Health (CCHS-MH). Respondents were 15 to 39 y of age ( n = 9228) and were categorized as: early emerging adults (15 to 22 y); late emerging adults (23 to 29 y); and, young adults (30 to 39 y). SUDs [alcohol or drug abuse/dependence (AAD or DAD)] were measured using the WHO Composite International Diagnostic Interview 3.0. The prevalence of SUDs was compared across age groups, and odds ratios (OR) and 95% confidence intervals (CI) were computed from logistic regression models adjusting for sociodemographic and health covariates. Analyses were weighted to maintain representativeness to the Canadian population. RESULTS: The prevalence of AAD was 8.0%, 6.6%, and 2.7% for early emerging adults, late emerging adults, and young adults, respectively. For DAD, the prevalence was 6.4%, 3.6%, and 1.3%. After covariate adjustment, early and late emerging adults had greater odds of reporting AAD (OR = 3.2, 95% CI = 2.2 to 4.9 and OR = 2.4, 95% CI = 1.6 to 3.4, respectively) or DAD (OR = 4.2, 95% CI = 2.5 to 7.0 and OR = 2.5, 95% CI = 1.6 to 4.1, respectively) compared with young adults. Differences between early and late emerging adults were not significant. CONCLUSION: Emerging adults are at increased odds for SUDs. Lack of differences between early and late emerging adults provide evidence of the extension of emerging adulthood into the late 20s. Findings have implications for the provision of screening and treatment of SUDs during this developmental period.
Entities:
Keywords:
alcohol abuse; alcohol dependence; drug abuse; drug dependence; emerging adult; substance use disorder; young adult
Authors: J Elisabeth Wells; Mark A Oakley Browne; Kate M Scott; Magnus A McGee; Joanne Baxter; Jesse Kokaua Journal: Aust N Z J Psychiatry Date: 2006-10 Impact factor: 5.744
Authors: Koen Demyttenaere; Ronny Bruffaerts; Sing Lee; José Posada-Villa; Vivianne Kovess; Matthias C Angermeyer; Daphna Levinson; Giovanni de Girolamo; Hideyuki Nakane; Zeina Mneimneh; Carmen Lara; Ron de Graaf; Kate Margaret Scott; Oye Gureje; Dan J Stein; Josep Maria Haro; Evelyn J Bromet; Ronald C Kessler; Jordi Alonso; Michael Von Korff Journal: Pain Date: 2007-03-09 Impact factor: 6.961
Authors: M Bernal; J M Haro; S Bernert; T Brugha; R de Graaf; R Bruffaerts; J P Lépine; G de Girolamo; G Vilagut; I Gasquet; J V Torres; V Kovess; D Heider; J Neeleman; R Kessler; J Alonso Journal: J Affect Disord Date: 2006-10-30 Impact factor: 4.839
Authors: M Codony; J Alonso; J Almansa; G Vilagut; A Domingo; A Pinto-Meza; A Fernández; A Serrano-Blanco; M Márquez; J M Haro Journal: Actas Esp Psiquiatr Date: 2007-09 Impact factor: 1.196
Authors: Christine Vogeli; Alexandra E Shields; Todd A Lee; Teresa B Gibson; William D Marder; Kevin B Weiss; David Blumenthal Journal: J Gen Intern Med Date: 2007-12 Impact factor: 5.128
Authors: Clarisse de Azambuja Farias; Taiane de Azevedo Cardoso; Marielle Moro da Silva; Francesca D'Angelo; Thaise Campos Mondin; Luciano Dias de Mattos Souza; Ricardo Azevedo da Silva; Flavio Kapczinski; Karen Jansen; Pedro V S Magalhães Journal: Front Psychiatry Date: 2022-08-24 Impact factor: 5.435